Aberdeen Group plc Sells 656,137 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Aberdeen Group cut its UnitedHealth stake by 63.6% in the third quarter, selling 656,137 shares; it retained 376,331 shares valued at about $138.1 million.
• UnitedHealth reported quarterly adjusted earnings of $4.69 per share, beating the $4.14 consensus, and revenue of $112.72 billion, above estimates. Revenue declined 0.4% year over year.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $463.93; the company also announced a quarterly dividend of $2.32 per share.

Aberdeen Group plc lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 376,331 shares of the healthcare conglomerate's stock after selling 656,137 shares during the quarter. Aberdeen Group plc's holdings in UnitedHealth Group were worth $138,144,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Nvwm LLC lifted its stake in UnitedHealth Group by 89.2% in the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate's stock valued at $26,000 after buying an additional 33 shares during the last quarter. Wellington Altus USA Inc. lifted its position in UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate's stock valued at $28,000 after purchasing an additional 33 shares during the last quarter. Security National Bank of SO Dak bought a new stake in UnitedHealth Group in the 2nd quarter valued at about $29,000. Compass Wealth Management LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at about $29,000. Finally, Aberdeen Wealth Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $31,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $2.49 during trading on Friday, hitting $407.62. The company had a trading volume of 3,467,004 shares, compared to its average volume of 5,162,694. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The business's 50-day moving average is $391.36 and its 200 day moving average is $365.66. The company has a market cap of $365.23 billion, a P/E ratio of 23.28, a PEG ratio of 1.47 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. The company had revenue of $112.72 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business's quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group's dividend payout ratio is presently 53.00%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Mizuho boosted their price objective on UnitedHealth Group from $493.00 to $500.00 and gave the stock an "outperform" rating in a research report on Thursday, October 22nd. Argus increased their price objective on UnitedHealth Group from $400.00 to $470.00 and gave the stock a "buy" rating in a report on Monday, July 20th. Wells Fargo & Company cut their target price on UnitedHealth Group from $526.00 to $487.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 27th. Finally, Stephens set a $500.00 price target on UnitedHealth Group in a research report on Friday, October 16th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $463.93.

UnitedHealth Group News Summary

Here's some of the latest news about UNH:

• Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
• Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
• Negative Sentiment: Optum Rx’s prescription volumes declined, highlighting ongoing membership-related pressure even as segment earnings improved. Whether efficiencies and biosimilar adoption can sustain profit growth will matter to investors. Article: Can UNH's Optum Rx Sustain Profit Growth as Prescription Volumes Fall?

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.